| Product Code: ETC071129 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Infectious Disease Biomarker Testing Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 France Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 France Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 France Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 France Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 France Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 France Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in France |
4.2.2 Growing awareness about the importance of early disease detection |
4.2.3 Technological advancements in biomarker testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker testing |
4.3.2 High cost associated with biomarker testing |
4.3.3 Limited access to advanced biomarker testing facilities in certain regions of France |
5 France Infectious Disease Biomarker Testing Market Trends |
6 France Infectious Disease Biomarker Testing Market, By Types |
6.1 France Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2027F |
6.1.4 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2027F |
6.1.5 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2027F |
6.2 France Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2027F |
6.2.3 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2027F |
6.2.4 France Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2027F |
6.2.5 France Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2027F |
6.2.6 France Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2027F |
6.2.7 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2027F |
6.3 France Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2027F |
6.3.3 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2027F |
6.3.4 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.5 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2027F |
6.3.6 France Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 France Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 France Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 France Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 France Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Average turnaround time for biomarker test results |
8.2 Number of new biomarkers identified for infectious diseases |
8.3 Rate of adoption of biomarker testing technologies in clinical practice |
9 France Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 France Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 France Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 France Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 France Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2021 |
10.2 France Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here